A new publication referencing terlipressin was released on September 1, 2026. Titled "Advances in the management of Hepatorenal syndrome," the article appeared in the journal Current Opinion in Nephrology and Hypertension.
The publication is listed under PubMed ID 42471785. No findings, outcomes, or data from the publication have been provided beyond its title, journal, and date.
Terlipressin is an approved compound. This item reflects only the appearance of this publication and does not summarize or interpret its content.
Readers interested in learning more about terlipressin can consult the compound overview for additional context.